The present invention relates to anti-influenza A virus monoclonal antibodies comprising a light chain comprising a CDR1 region consisting of a sequence of SEQ ID NO: 7, a CDR2 region consisting of a sequence of SEQ ID NO: 2 and a CDR3 region consisting of a sequence of SEQ ID NO: 8, and a heavy chain comprising a CDR1 region consisting of a sequence of SEQ ID NO: 9, a CDR2 region consisting of a sequence of SEQ ID NO: 10 and a CDR3 region consisting of a sequence of SEQ ID NO: 11